These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

462 related items for PubMed ID: 8658369

  • 1. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
    Ikeda A, Nishimura K, Koyama H, Tsukino M, Mishima M, Izumi T.
    Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone.
    Ikeda A, Nishimura K, Koyama H, Izumi T.
    Chest; 1995 Feb; 107(2):401-5. PubMed ID: 7842768
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP, Smeets JJ, Sledsens TJ, Wald FD, Cornelissen PJ.
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [Abstract] [Full Text] [Related]

  • 8. Bronchodilating effect of combined therapy with ipratropium bromide and ondansetron in patients with COPD.
    Pauwels R, Joos GF, Fogarty C, Faiferman I, Hirschberg S, Vessey R, Wouters EF.
    Pulm Pharmacol Ther; 2008 Sep; 21(2):385-92. PubMed ID: 18023600
    [Abstract] [Full Text] [Related]

  • 9. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
    Levin DC, Little KS, Laughlin KR, Galbraith JM, Gustman PM, Murphy D, Kram JA, Hardie G, Reuter C, Ostransky D, McFarland K, Petty TL, Silvers W, Rennard SI, Mueller M, Repsher LH, Zuwallack RL, Vale R.
    Am J Med; 1996 Jan 29; 100(1A):40S-48S. PubMed ID: 8610716
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic equivalence of a fenoterol/ipratropium bromide combination (Berodual) inhaled as a dry powder and by metered dose inhaler in chronic obstructive airway disease.
    Rammeloo RH, Luursema PB, Sips AP, Beumer HM, Wald FD, Cornelissen PJ.
    Respiration; 1992 Jan 29; 59(6):322-6. PubMed ID: 1488568
    [Abstract] [Full Text] [Related]

  • 11. The additive effect of theophylline on a high-dose combination of inhaled salbutamol and ipratropium bromide in stable COPD.
    Nishimura K, Koyama H, Ikeda A, Sugiura N, Kawakatsu K, Izumi T.
    Chest; 1995 Mar 29; 107(3):718-23. PubMed ID: 7874943
    [Abstract] [Full Text] [Related]

  • 12. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B, Markham A.
    Drugs Aging; 2001 Mar 29; 18(6):441-72. PubMed ID: 11419918
    [Abstract] [Full Text] [Related]

  • 13. Effects of formoterol (Oxis Turbuhaler) and ipratropium on exercise capacity in patients with COPD.
    Liesker JJ, Van De Velde V, Meysman M, Vincken W, Wollmer P, Hansson L, Kerstjens HA, Qvint U, Pauwels RA.
    Respir Med; 2002 Aug 29; 96(8):559-66. PubMed ID: 12195835
    [Abstract] [Full Text] [Related]

  • 14. [A comparison of bronchodilating drugs in the treatment of stable COPD].
    Nishimura K, Koyama H, Izumi T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May 29; 30(5):835-43. PubMed ID: 1385837
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A multicenter study of nebulized bronchodilator solutions in chronic obstructive pulmonary disease.
    Friedman M.
    Am J Med; 1996 Jan 29; 100(1A):30S-39S. PubMed ID: 8610715
    [Abstract] [Full Text] [Related]

  • 17. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease.
    O'Donnell DE, Lam M, Webb KA.
    Am J Respir Crit Care Med; 1998 Nov 29; 158(5 Pt 1):1557-65. PubMed ID: 9817708
    [Abstract] [Full Text] [Related]

  • 18. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study.
    Gross NJ, Petty TL, Friedman M, Skorodin MS, Silvers GW, Donohue JF.
    Am Rev Respir Dis; 1989 May 29; 139(5):1188-91. PubMed ID: 2523681
    [Abstract] [Full Text] [Related]

  • 19. Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease.
    Newnham DM, Dhillon DP, Winter JH, Jackson CM, Clark RA, Lipworth BJ.
    Thorax; 1993 Nov 29; 48(11):1151-5. PubMed ID: 8296260
    [Abstract] [Full Text] [Related]

  • 20. Oxitropium bromide improves exercise performance in patients with COPD.
    Ikeda A, Nishimura K, Koyama H, Sugiura N, Izumi T.
    Chest; 1994 Dec 29; 106(6):1740-5. PubMed ID: 7988193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.